For instance, Dendreon did not utilize a patient specific tumor lysate, they did not use tumor tissue, they did not store it, transport it, store it again perhaps for later use, or ever track it. They did about 1/2 perhaps of what NWBO does, in that context. It was not a part of their manufacturing process at all. Plus, again, it was a 1 and done, single shot manufacturing process, in this case they are doing an entirely different, personnel intensive process that apparently has many steps, then shots are individually put into injection vials and stored for dispersal at the appropriate time, which requires tracking, data systems, storage systems, processes and human handling. I would not want to overshoot on the notion that they are not doing much, or not much more than Dendreon. That seems like it was a different thing altogether.
Market Data 
Markets 
AI
